Content about New Jersey

November 1, 2011

A new online healthcare service powered by Healthcare Resources Online and developed for members of the American Diabetes Association has made its debut.

November 1, 2011

Watson Pharmaceuticals had sales of $1.1 billion and profits of $68.1 million in third quarter 2011, the drug maker said in an earnings statement Tuesday.

November 1, 2011

YummyEarth has expanded its lineup of organic candy to include sour jelly beans.

October 31, 2011

Watson Pharmaceuticals and a partnering company are barred from launching a generic version of a blood-thinning drug under a federal court decision issued Friday.

October 31, 2011

A Johnson & Johnson subsidiary has sent a regulatory application to the Food and Drug Administration seeking approval for one of its drugs in treating diabetes-related pain.

October 27, 2011

A company focused on developing niche generic and specialty pharmaceutical products has received regulatory approval from the Food and Drug Administration for its version of a psychiatric drug.

October 26, 2011

Robitussin has launched a new campaign in line with the start of the cold and flu season called the Simple Acts of Relief program.

October 24, 2011

A drug made by Coria Labs for treating acne now is available in a convenient, ready-to-use pump, the drug maker said Monday.

October 21, 2011

The Food and Drug Administration has approved a new formulation of a testosterone therapy made by Watson Pharmaceuticals, the drug maker said Friday.

October 19, 2011

Armada Health Care announced that its annual Armada Specialty Pharmacy Summit will feature Karl Rove and Robert Gibbs as keynote speakers.

October 19, 2011

Ortho Clinical Diagnostics, in partnership with the National Association of Chronic Disease Directors, on Wednesday released a survey that determined consumers would more likely discuss health-and-wellness plans with their doctors, and take action, if they understood their blood test numbers.

October 18, 2011

Johnson & Johnson Tuesday morning pledged significant support behind the relaunch of several McNeil Consumer products into the marketplace in 2012, and feels confident impacted brands — Tylenol and Motrin, among others — will be able to recapture market share, despite significant private-label erosion.

October 17, 2011

Archimedes Pharma has launched a new drug for breakthrough cancer pain, the drug maker said Monday.

October 17, 2011

Generic drug maker Watson Pharmaceuticals is seeking Food and Drug Administration approval for a generic treatment for attention deficit hyperactivity disorder, the company said.

October 11, 2011

Unilever on Monday announced a makeover for its Slim-Fast brand with the introduction of new, convenient on-the-go bottles.

October 10, 2011

Reckitt Benckiser’s Clearasil skin care brand has launched a Facebook search for consumer brand ambassadors.

October 7, 2011

Unilever’s Gina Boswell, who was recently appointed EVP personal care for North America, has been selected as a 2011 Achiever of the Year, one of the highest awards bestowed in the beauty industry, by nonprofit Cosmetic Executive Women.

October 7, 2011

Reckitt Benckiser has achieved 75% of its target goal for the company's Carbon 20 program, RB said in its sustainability report.

October 7, 2011

Venture Products earlier this week announced a new line of yoga and fitness accessories under its Shock Athletic brand name. These products complement Venture’s existing lineup of yoga mats.

October 7, 2011

Watson Pharmaceuticals is looking to become the first to market a generic version of a painkiller made by Pfizer, the drug maker said Friday.

October 6, 2011

Merck chairman Richard Clark is retiring, the company said Thursday.

October 5, 2011

The Food and Drug Administration has accepted a regulatory approval application from Merck and Ariad Pharmaceuticals for a new drug to treat soft-tissue and bone cancers, the drug makers said Wednesday.

October 4, 2011

Amneal last month launched its version of an epilepsy treatment.

October 4, 2011

The Medicines Co. and generic drug maker Teva Pharmaceutical Industries have reached a settlement that will allow Teva to start selling a generic version of one of MDCO's drugs by the end of the decade.

© 2014 Drug Store News. All Rights Reserved.